Central Laboratories White Papers & Articles

  1. Harnessing AI for Pre-Award Landscape Analysis And Site Selection 1/16/2026

    AI-driven insights transform site selection and feasibility, enabling faster decisions and reducing risk. Predictive modeling and real-time data improve pre-award planning and trial outcomes.

  2. Clinical Development Crystal Ball: What To Watch In 2026 1/16/2026

    Explore how AI integration, remote assessment, and precision measurement are reshaping clinical trials in 2026 to improve data quality and patient outcomes.

  3. Why Risk-Based Thinking Is Transforming Life Sciences Validation 1/16/2026

    The FDA’s CSA framework replaces traditional CSV with a risk-based approach, reducing inefficiencies and enabling faster innovation. Learn why this shift matters for your organization.

  4. Quality Management Fundamentals For Modern Compliance 1/16/2026

    Manual quality processes can’t keep up with today’s compliance demands. Discover why an intelligent, digital QMS is essential for reducing risk, improving efficiency, and building a strong foundation.

  5. Predictions For 2026 In Life Sciences 1/15/2026

    Experts predict 2026 trends: more pragmatic trial design, expanded use of data and AI for patient matching, and registration and reporting of results for all human trials.

  6. Empower Your Trial With Data And Evidence 1/14/2026

    Fuel your clinical development and decision-making with insights from fit-for-purpose data and evidence.

  7. Decision-Ready Data Restores Clinical Teams' Confidence 1/14/2026

    The data underlying strategic decisions made by clinical teams often remain fragmented, backward-looking, or insufficiently validated. These teams need decision-ready data that brings clarity where it matters most.

  8. Quantifying Potential: Leveraging Data To Showcase Biotech Value 1/14/2026

    Biotechs must use data-driven insights to prove asset potential. Real-world evidence and predictive analytics validate differentiation, forecast market opportunity, and build investor confidence.

  9. Accelerating Parkinson's Disease Clinical Research Through Recruitment Capabilities 1/14/2026

    Centralized PD trials cut variability, speed enrollment, and enable genetic stratification, delivering high‑quality data and faster progress from early‑phase research to late‑stage development.

  10. Navigating The Enrollment Bottleneck In Early Oncology Trials 1/12/2026

    Slow oncology trial enrollment raises costs and delays progress. AI prescreening, patient-focused engagement, and early pharmacology studies help accelerate recruitment and optimize trial design.